AI Article Synopsis
- Mucosal leishmaniasis (ML) is a rare and persistent type of leishmaniasis that leads to serious lesions in the mucosal areas of the nose and throat.
- A 29-year-old woman had an intranasal polyp that kept coming back even after surgery for three years.
- Eventually, her condition was identified as nasal leishmaniasis.
Article Abstract
Mucosal leishmaniasis (ML) is a chronic and rare form of leishmaniasis that causes malignant lesions in the mucosa of the nasal, pharyngeal, and laryngeal regions. We describe a 29-year-old woman who had been suffering from an intranasal polyp for 3 years. The polyp recurred annually after surgical removal, and was diagnosed as nasal leishmaniasis.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10548795 | PMC |
| http://dx.doi.org/10.1177/11795476231186913 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Time to recovery from visceral leishmaniasis and its predictors of mature visceral leishmaniasis patients admitted at Metema Hospital, Metema, Ethiopia.
Sci Rep
December 2024
Department of Statistics, College of Natural and Computational Sciences, Gambella University, Gambella, Ethiopia.
Visceral leishmaniasis (VL) is a neglected tropical disease that mostly affects the working-class and impoverished segments of society, having a significant negative effect on the economic development of the affected nation. While anti-leishmanial medications lower mortality among VL patients, patients may still die or require more time to recover (TTR) while receiving treatment. In this regard, there are limited studies in Ethiopia.
View Article and Find Full Text PDFLeishmaniasis in Humans and Animals: A One Health Approach for Surveillance, Prevention and Control in a Changing World.
Trop Med Infect Dis
October 2024
Department of Health Sciences, University of Florence, 50134 Florence, Italy.
Leishmaniasis is classified as a neglected tropical disease (NTD), caused by protozoan parasites of the genus , which are transmitted to humans and other animals through the bite of infected female phlebotomine sandflies. There are three forms of the disease: cutaneous leishmaniasis (CL) manifested by ulcers and scars; systemic or visceral leishmaniasis (VL), which can lead to life-threatening complications if left untreated; and mucocutaneous leishmaniasis (MCL), which can destroy the mucous membranes of the nose, mouth and throat. Human leishmaniasis is endemic in many countries across Africa, Asia, Southern Europe, the Middle East, and Central and South America.
View Article and Find Full Text PDFComplicated Mucocutaneous Leishmaniasis With Superimposed Cellulitis in an Immunocompromised Patient: A Case Report.
Cureus
October 2024
Department of Pathology, King Saud University, Riyadh, SAU.
Article Synopsis
- Leishmaniasis is a protozoal infection that can manifest in three forms: cutaneous (CL), mucocutaneous (MCL), and visceral, with CL being the most common, but it can be hard to diagnose when lesions are diffuse.
- A 54-year-old man with a history of MCL, systemic lupus erythematosus, and non-Hodgkin's lymphoma presented with widespread skin lesions, leading to the diagnosis of MCL with cellulitis after biopsy and PCR tests confirmed the presence of leishmania.
- Despite having reliable diagnostic tests and treatment options like intravenous liposomal amphotericin B, the clinical suspicion for leishmaniasis can be challenging since its symptoms often mimic other
Case Report: Cutaneous Leishmaniasis-A Hidden Disease in Côte d'Ivoire.
Am J Trop Med Hyg
November 2024
Department of Tropical Medicine, Tulane School of Public Health and Tropical Medicine, New Orleans, Louisiana.
Article Synopsis
- - Cutaneous leishmaniasis (CL) is a neglected tropical disease with very few cases reported in Côte d'Ivoire since its identification in 1967, highlighting a significant gap in awareness and diagnosis.
- - A recent case involved a 15-year-old male with skin lesions and accompanying symptoms, which was confirmed as CL through a biopsy, but he sadly passed away before treatment could be administered.
- - The rarity of CL in Côte d'Ivoire leads to low awareness among healthcare professionals, necessitating urgent strategies for better education on diagnosis and treatment, along with the need for improved epidemiological data.
Hemophagocytic lymphohistiocytosis secondary to visceral leishmaniasis: A case report of a rare complication of visceral leishmaniasis.
IDCases
August 2024
Department of Pediatrics and Child Health, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Hemophagocytic lymphohistiocytosis (HLH) is a rare, potentially life-threatening clinical syndrome characterized by hyperactivation of inflammatory mediators and harmful end-organ damage Visceral leishmaniasis (VL)-induced HLH is a rare disease with significant diagnostic and management implications. Herein, we present a case of secondary HLH as a complication of visceral leishmaniasis in a two-year-old toddler. A 2-year-old male toddler was admitted for evaluation of a prolonged 4-week fever.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!